A detailed history of Eam Investors, LLC transactions in Geron Corp stock. As of the latest transaction made, Eam Investors, LLC holds 745,614 shares of GERN stock, worth $2.49 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
745,614
Previous 744,270 0.18%
Holding current value
$2.49 Million
Previous $3.16 Million 7.29%
% of portfolio
0.58%
Previous 0.57%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.17 - $4.99 $5,604 - $6,706
1,344 Added 0.18%
745,614 $3.39 Million
Q2 2024

Aug 12, 2024

BUY
$3.1 - $5.09 $2.31 Million - $3.79 Million
744,270 New
744,270 $3.16 Million
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $695,229 - $1.22 Million
416,305 New
416,305 $974,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.26B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.